HBVZ10 exhibits robust in vivo potency and synergizes with entecavir to drive efficient cccDNA elimination and HBsAg seroclearance

Zhang Bai-HuaZhou YuanpingWu YukunHorrigan StephenLuckenbaugh LauraHu JianmingZoulim FabienZhang Yong-Yuan2026-09-232026-1010.1016/j.antiviral.2026.106518https://pubs.cidrz.org/handle/123456789/13732HBVZ10 exhibits robust in vivo potency and synergizes with entecavir to drive efficient cccDNA elimination and HBsAg seroclearancehttps://doi.org/10.1016/j.antiviral.2026.106518